Abbott Laboratories Watch

from 10-K 107 pages U.S. $5,000,000,000 Five Year Credit Agreement Dated as of January 29, 2024 Among Abbott Laboratories, as Borrower, and Various Financial Institutions, as Lenders, and Jpmorgan Chase Bank, N.A., as Administrative Agent, and Barclays Bank PLC Bank of America, N.A. and Morgan Stanley Senior Funding, Inc. as Syndication Agents Jpmorgan Chase Bank, N.A. Barclays Bank PLC Bofa Securities, Inc. and Morgan Stanley Senior Funding, Inc. Joint Lead Arrangers and Joint Book Runners

from 10-K 107 pages ​ U.S. $5,000,000,000 Five Year Credit Agreement Dated as of November 12, 2020 Among Abbott Laboratories, as Borrower, and Various Financial Institutions, as Lenders, and Jpmorgan Chase Bank, N.A., as Administrative Agent, and Barclays Bank PLC Bank of America, N.A. and Morgan Stanley Senior Funding, Inc. as Syndication Agents Jpmorgan Chase Bank, N.A. Barclays Bank PLC Bofa Securities, Inc. and Morgan Stanley Senior Funding, Inc. Joint Lead Arrangers and Joint Book Runners

from 10-K 88 pages U.S. $5,000,000,000 Five Year Credit Agreement Dated as of November 30, 2018 Among Abbott Laboratories, as Borrower, and Various Financial Institutions, as Lenders, and Jpmorgan Chase Bank, N.A., as Administrative Agent, and Barclays Bank PLC Bank of America, N.A. and Morgan Stanley Senior Funding, Inc. as Syndication Agents Jpmorgan Chase Bank, N.A., Barclays Bank PLC Merrill Lynch, Pierce, Fenner & Smith, Incorporated and Morgan Stanley Senior Funding, Inc. Joint Lead Arrangers and Joint Book Runners

from 10-K 24 pages This First Amendment, Dated as of September 29, 2017 (This “Amendment Agreement”), to That Certain Term Loan Agreement, Dated as of July 31, 2017 (As Amended From Time to Time Prior to the Date Hereof, the “Existing Credit Agreement”; and the Existing Credit Agreement as Amended by the Amendments (As Defined Below), the “Amended Credit Agreement”), by and Among Abbott Laboratories, as Borrower (The “Borrower”), the Lenders Party Thereto (The “Lenders”), and Bank of America, N.A., as Administrative Agent (The “Administrative Agent”), Is Made by and Among the Borrower, the Lenders and the Administrative Agent. Unless Otherwise Defined Herein, Terms Defined in the Amended Credit Agreement (As Defined Below) and Used Herein Shall Have the Meanings Given to Them in the Amended Credit Agreement. Whereas, the Effective Date Occurred on July 31, 2017; Whereas, the Borrower Has Requested Certain Amendments to the Existing Credit Agreement; Whereas, in Order to Effect the Requested Amendments, the Borrower and the Lenders Desire to Amend, as of the Amendment Effective Date (As Defined Below), the Existing Credit Agreement, Subject to the Terms and Conditions Set Forth Herein; Now, Therefore, in Consideration of the Foregoing and for Other Good and Valuable Consideration, the Receipt and Sufficiency of Which Are Hereby Acknowledged, the Parties Hereto Hereby Agree as Follows

from 10-K 97 pages Term Loan Agreement Dated as of July 31, 2017 Among Abbott Laboratories as the Borrower, the Guarantors Referred to Herein, Bank of America, N.A., as Administrative Agent and Lender, and the Other Lenders Party Hereto * * * * Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley Senior Funding, Inc. and Barclays Bank PLC, as Joint Lead Arrangers and Joint Bookrunners, Morgan Stanley Senior Funding, Inc. and Barclays Bank PLC, as Syndication Agents

from 10-Q 70 pages U.S. $5,000,000,000 Five Year Credit Agreement Dated as of July 10, 2014 Among Abbott Laboratories as Borrower, and Various Financial Institutions, as Lenders, and Bank of America, N.A. as Administrative Agent, and Barclays Bank PLC Jpmorgan Chase Bank N.A. and Morgan Stanley Senior Funding, Inc. as Syndication Agents Merrill Lynch, Pierce, Fenner & Smith Incorporated Barclays Bank PLC J.P. Morgan Securities LLC and Morgan Stanley Senior Funding, Inc. Joint Lead Arrangers and Joint Book Runners

from 10-Q 28 pages This First Amendment, Dated as of September 29, 2017 (This “Amendment Agreement”), to That Certain Term Loan Agreement, Dated as of July 31, 2017 (As Amended From Time to Time Prior to the Date Hereof, the “Existing Credit Agreement”; and the Existing Credit Agreement as Amended by the Amendments (As Defined Below), the “Amended Credit Agreement”), by and Among Abbott Laboratories, as Borrower (The “Borrower”), the Lenders Party Thereto (The “Lenders”), and Bank of America, N.A., as Administrative Agent (The “Administrative Agent”), Is Made by and Among the Borrower, the Lenders and the Administrative Agent. Unless Otherwise Defined Herein, Terms Defined in the Amended Credit Agreement (As Defined Below) and Used Herein Shall Have the Meanings Given to Them in the Amended Credit Agreement. Whereas, the Effective Date Occurred on July 31, 2017; Whereas, the Borrower Has Requested Certain Amendments to the Existing Credit Agreement; Whereas, in Order to Effect the Requested Amendments, the Borrower and the Lenders Desire to Amend, as of the Amendment Effective Date (As Defined Below), the Existing Credit Agreement, Subject to the Terms and Conditions Set Forth Herein; Now, Therefore, in Consideration of the Foregoing and for Other Good and Valuable Consideration, the Receipt and Sufficiency of Which Are Hereby Acknowledged, the Parties Hereto Hereby Agree as Follows

from 10-Q 110 pages Term Loan Agreement Dated as of July 31, 2017 Among Abbott Laboratories as the Borrower, the Guarantors Referred to Herein, Bank of America, N.A., as Administrative Agent and Lender, and the Other Lenders Party Hereto * * * * Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley Senior Funding, Inc. and Barclays Bank PLC, as Joint Lead Arrangers and Joint Bookrunners, Morgan Stanley Senior Funding, Inc. and Barclays Bank PLC, as Syndication Agents

from 10-K 78 pages Amended and Restated Term Loan Agreement Dated as of the Restatement Date Among Vault Merger Sub, Llc(1), as the Borrower, the Guarantors Referred to Herein, Bank of America, N.A., as Administrative Agent and Lender, and the Other Lenders Party Hereto * * * * Merrill Lynch, Pierce, Fenner & Smith Incorporated, Wells Fargo Securities, LLC, the Bank of Tokyo-Mitsubishi Ufj, Ltd., and U.S. Bank National Association, as Joint Lead Arrangers and Joint Bookrunners

from 10-K 102 pages 120-Day Bridge Term Loan Agreement Dated as of December 13, 2016 Among Abbott Laboratories as the Borrower, the Guarantors Referred to Herein, Bank of America, N.A., as Administrative Agent and Lender, and the Other Lenders Party Hereto * * * * Merrill Lynch, Pierce, Fenner & Smith Incorporated, as Sole Lead Arranger and Sole Bookrunner, Barclays Bank PLC and Morgan Stanley Senior Funding, Inc., as Co-Arrangers and Syndication Agents II